Essex Financial Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,101
Closed -$280K 641
2024
Q2
$280K Hold
4,101
0.02% 500
2024
Q1
$278K Hold
4,101
0.03% 437
2023
Q4
$253K Hold
4,101
0.03% 434
2023
Q3
$242K Hold
4,101
0.03% 412
2023
Q2
$245K Hold
4,101
0.03% 404
2023
Q1
$240K Hold
4,101
0.03% 429
2022
Q4
$254K Hold
4,101
0.03% 405
2022
Q3
$232K Hold
4,101
0.03% 400
2022
Q2
$262K Hold
4,101
0.03% 389
2022
Q1
$266K Buy
4,101
+801
+24% +$50.8K 0.03% 412
2021
Q4
$220K Hold
3,300
0.02% 455
2021
Q3
$201K Hold
3,300
0.02% 447
2021
Q2
$204K Buy
+3,300
New +$201K 0.03% 434
2018
Q2
Sell
-4,200
Closed -$207K 310
2018
Q1
$207K Buy
+4,200
New +$216K 0.04% 327
2016
Q2
Sell
-4,890
Closed -$223K 311
2016
Q1
$223K Hold
4,890
0.06% 269
2015
Q4
$264K Hold
4,890
0.06% 250
2015
Q3
$241K Buy
4,890
+1,020
+26% +$58.5K 0.06% 270
2015
Q2
$226K Hold
3,870
0.06% 288
2015
Q1
$222K Sell
3,870
-1,422
-27% -$77.8K 0.06% 286
2014
Q4
$267K Hold
5,292
0.07% 247
2014
Q3
$248K Hold
5,292
0.07% 246
2014
Q2
$238K Hold
5,292
0.07% 259
2014
Q1
$223K Hold
5,292
0.07% 253
2013
Q4
$208K Buy
+5,292
New +$199K 0.07% 259

Other funds holding IHE